A US military agency is investing $100m in genetic extinction technologies that could wipe out malarial mosquitoes, invasive rodents or other species, emails released under freedom of information rules show.
The UN Convention on Biological Diversity (CBD) is debating whether to impose a moratorium on the gene research next year and several southern countries fear a possible military application.
Gene-drive research has been pioneered by an Imperial College London professor, Andrea Crisanti, who confirmed he has been hired by Darpa on a $2.5m contract to identify and disable such drives.
Human augmentation has, at least at the beginning, a very limited number of very specific use cases. The supersoldier certainly is the top one.